4 unchanged sentences
Amended and Restated Bylaws
−Removed: Separation and Consulting Agreement dated January 20, 2021 between Registrant and Brandi Roberts
−Removed: Separation and Consulting Agreement dated March 29, 2021 between Registrant and Chase C.
−Removed: Certification of Chief Executive Officer and Chief Financial Officer pursuant to Form of Rule 13a-14(a), as Adopted Pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
−Removed: Certification
−Removed: of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C.
−Removed: Section 1350, as Adopted Pursuant to Section
−Removed: 906 of the Sarbanes-Oxley Act of 2002
+Added: First Amendment to License Agreement dated April 16, 2021 between Cancer Research Technology Limited and Registrant
+Added: First Amendment to Separation and Consulting Agreement dated May 21, 2021 between Registrant and Chase C.
+Added: Employment Agreement dated June 8, 2021, between Registrant and Kevin Leon Cook
+Added: Certification of Principal Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
+Added: Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Instance Document
8 unchanged sentences
Indicates management contract or compensatory plan
−Removed: to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
−Removed: by the undersigned, thereunto duly authorized.
+Added: to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
+Added: the undersigned, thereunto duly authorized.
CELL THERAPEUTICS, INC.
Executive Officer
−Removed: behalf of the Registrant and in his capacity as Principal Financial Officer)
+Added: Kevin Leon Cook
+Added: Chief Financial
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.